Condensed Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022		30,193
Beginning balance at Dec. 31, 2022	$ 239,812	$ 28	$ 762,380	$ (522,200)	$ (396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with employee equity incentive plans, net (in shares)		270
Issuance of common stock in connection with employee equity incentive plans, net	905	$ 2	903
Stock-based compensation	19,899		19,899
Net loss	(39,109)			(39,109)
Net change in unrealized (loss) gain on marketable securities	327				327
Cumulative translation adjustment	0
Ending balance (in shares) at Mar. 31, 2023		30,463
Ending balance at Mar. 31, 2023	$ 221,834	$ 30	783,182	(561,309)	(69)
Beginning balance (in shares) at Dec. 31, 2023	30,954	30,954
Beginning balance at Dec. 31, 2023	$ 210,097	$ 31	855,784	(645,606)	(112)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with employee equity incentive plans, net (in shares)	9	372
Issuance of common stock in connection with employee equity incentive plans, net	$ 604		604
Purchase of capped call transactions	(72,407)		(72,407)
Purchase of treasury stock (in shares)		(229)
Purchase of treasury stock	(25,000)					(25,000)
Stock-based compensation	22,640		22,640
Net loss	(45,667)			(45,667)
Net change in unrealized (loss) gain on marketable securities	(54)				(54)
Cumulative translation adjustment	$ 77				77
Ending balance (in shares) at Mar. 31, 2024	31,097	31,097
Ending balance at Mar. 31, 2024	$ 90,290	$ 31	$ 806,621	$ (691,273)	$ (89)	$ (25,000)